<p>添加</p>
<p><img src="https://imageproxy.pbkrs.com/https://cdn.rttnews.com/images/v4/RTTNews-Logo-224x61.png?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://cdn.rttnews.com/images/v4/RTTNews-Logo-224x61.png"/></p>
<p>將其添加為您在 Google 上的首選新聞來源</p>
<p><img src="https://imageproxy.pbkrs.com/https://cdn.rttnews.com/images/v4/google.png?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://cdn.rttnews.com/images/v4/google.png"/></p>
<p>立即添加</p>
<p>週五，幾家生物科技和醫療保健公司在盤後交易中表現出顯著漲幅，投資者對與藥物開發、醫療服務和融資更新相關的公司表現出 renewed interest。</p>
<p>Zentalis Pharmaceuticals, Inc. (ZNTL) 領漲，漲幅達到 17.65%，收於 4.40 美元，盤後上漲 0.66 美元。儘管週五沒有新的消息，但該公司最近在 2026 年 1 月 6 日提供了一份企業更新，強調了關鍵里程碑和預計在其 azenosertib 開發項目中的動力。這一更新似乎增強了投資者對公司管道進展的信心。</p>
<p>LifeMD, Inc. (LFMD) 也實現了強勁的漲幅，攀升 12.18% 至 4.33 美元，上漲 0.47 美元。這一變動發生在 LifeMD 宣佈與 Citizens Bank, N.A.完成一項新的高級擔保循環信貸設施的幾天後。該設施提供高達 5000 萬美元的總可用額度，其中 3000 萬美元已承諾，另外 2000 萬美元為可選擇的額度。管理層強調在關閉時沒有提取餘額，稱手頭現金充足，預計現金流能夠支持有機增長計劃。</p>
<p>NanoViricides, Inc. (NNVC) 上漲 11.11%，盤後收於 1.24 美元，漲幅為 0.12 美元。該公司週五沒有發佈新聞，但該股在交易結束時吸引了投機興趣。</p>
<p>Intelligent Bio Solutions Inc. (INBS) 漲幅為 9.10%，收於 19.55 美元，上漲 1.63 美元。儘管沒有新的公告，該股仍然受到投資者對生物科技行業的熱情推動。</p>
<p>IO Biotech, Inc. (IOBT) 上漲 6.49%，至 0.60 美元，盤後上漲 0.037 美元。該公司週五沒有新聞，但這一變動表明在較低價格水平上存在抄底活動。</p>
<p>Neurogene Inc. (NGNE) 上漲 2.06%，收於 18.29 美元，上漲 0.37 美元。本週早些時候，Neurogene 宣佈其管理團隊將參加第 44 屆年度摩根大通醫療保健會議，屆時他們將介紹公司概況並與投資者會面。</p>
<p>China SXT Pharmaceuticals, Inc. (SXTC) 也上漲 2.06%，至 18.29 美元，上漲 0.37 美元。該公司最近披露與單一投資者達成了一項最終協議，購買 66666666 股 A 類普通股（或預先融資的認股權證），每股價格為 0.15 美元，屬於註冊直接發行。這一融資舉措突顯了其加強資本狀況的持續努力。</p>
<p>如需評論和反饋，請聯繫：editorial@rttnews.com</p>
<p>商業新聞</p>

LFMD

ZNTL

NNVC

<p>幾家生物科技和醫療保健公司在盤後交易中實現了顯著漲幅，其中 Zentalis Pharmaceuticals 上漲了 17.65%，至 4.40 美元。LifeMD 在宣佈新的信貸融資後上漲了 12.18%，而 NanoViricides 上漲了 11.11%。其他值得注意的漲幅公司包括 Intelligent Bio Solutions、IO Biotech 和 Neurogene，後者參與了摩根大通醫療保健會議。中國 SXT Pharmaceuticals 在達成融資協議以增強其資本實力後也有所上漲。總體來看，投資者對藥物開發和醫療服務的興趣似乎正在上升</p>

<p>Add</p>
<div class="lb-trans"><p>添加</p>
</div><p><img src="https://imageproxy.pbkrs.com/https://cdn.rttnews.com/images/v4/RTTNews-Logo-224x61.png" alt="" original-src="https://cdn.rttnews.com/images/v4/RTTNews-Logo-224x61.png"/></p>
<p>as your preferred news source on Google</p>
<div class="lb-trans"><p>將其添加為您在 Google 上的首選新聞來源</p>
</div><p><img src="https://imageproxy.pbkrs.com/https://cdn.rttnews.com/images/v4/google.png" alt="" original-src="https://cdn.rttnews.com/images/v4/google.png"/></p>
<p>Add Now</p>
<div class="lb-trans"><p>立即添加</p>
</div><p>Several biotech and healthcare names posted notable gains in after-hours trading on Friday, with investors showing renewed interest in companies tied to drug development, healthcare services, and financing updates.</p>
<div class="lb-trans"><p>週五，幾家生物科技和醫療保健公司在盤後交易中表現出顯著漲幅，投資者對與藥物開發、醫療服務和融資更新相關的公司表現出 renewed interest。</p>
</div><p>Zentalis Pharmaceuticals, Inc. (ZNTL) led the pack, surging 17.65% to close at $4.40, up $0.66 in the after-hours session. While there was no fresh news on Friday, the company recently provided a corporate update on January 6, 2026, highlighting key milestones and expected momentum in its azenosertib development program for the year. The update appears to have bolstered investor confidence in the company's pipeline progress.</p>
<div class="lb-trans"><p>Zentalis Pharmaceuticals, Inc. (ZNTL) 領漲，漲幅達到 17.65%，收於 4.40 美元，盤後上漲 0.66 美元。儘管週五沒有新的消息，但該公司最近在 2026 年 1 月 6 日提供了一份企業更新，強調了關鍵里程碑和預計在其 azenosertib 開發項目中的動力。這一更新似乎增強了投資者對公司管道進展的信心。</p>
</div><p>LifeMD, Inc. (LFMD) also saw strong gains, climbing 12.18% to $4.33, up $0.47. The move comes days after LifeMD announced the closing of a new senior secured revolving credit facility with Citizens Bank, N.A. The facility provides up to $50 million in total availability, with $30 million committed and an additional $20 million accordion option. Management emphasized that no balance was drawn at closing, citing sufficient cash on hand and expected cash flow to fund organic growth initiatives.</p>
<div class="lb-trans"><p>LifeMD, Inc. (LFMD) 也實現了強勁的漲幅，攀升 12.18% 至 4.33 美元，上漲 0.47 美元。這一變動發生在 LifeMD 宣佈與 Citizens Bank, N.A.完成一項新的高級擔保循環信貸設施的幾天後。該設施提供高達 5000 萬美元的總可用額度，其中 3000 萬美元已承諾，另外 2000 萬美元為可選擇的額度。管理層強調在關閉時沒有提取餘額，稱手頭現金充足，預計現金流能夠支持有機增長計劃。</p>
</div><p>NanoViricides, Inc. (NNVC) advanced 11.11%, finishing at $1.24 after-hours, a gain of $0.12. The company did not release news on Friday, but the stock attracted speculative interest late in the session.</p>
<div class="lb-trans"><p>NanoViricides, Inc. (NNVC) 上漲 11.11%，盤後收於 1.24 美元，漲幅為 0.12 美元。該公司週五沒有發佈新聞，但該股在交易結束時吸引了投機興趣。</p>
</div><p>Intelligent Bio Solutions Inc. (INBS) posted a 9.10% jump, closing at $19.55, up $1.63. Despite no new announcements, the stock continued to draw momentum from investor enthusiasm in the biotech sector.</p>
<div class="lb-trans"><p>Intelligent Bio Solutions Inc. (INBS) 漲幅為 9.10%，收於 19.55 美元，上漲 1.63 美元。儘管沒有新的公告，該股仍然受到投資者對生物科技行業的熱情推動。</p>
</div><p>IO Biotech, Inc. (IOBT) rose 6.49% to $0.60, adding $0.037 in after-hours trading. The company had no news on Friday, but the move suggests bargain-hunting activity at lower price levels.</p>
<div class="lb-trans"><p>IO Biotech, Inc. (IOBT) 上漲 6.49%，至 0.60 美元，盤後上漲 0.037 美元。該公司週五沒有新聞，但這一變動表明在較低價格水平上存在抄底活動。</p>
</div><p>Neurogene Inc. (NGNE) gained 2.06%, closing at $18.29, up $0.37. Earlier in the week, Neurogene announced that its management team will participate in the 44th Annual J.P. Morgan Healthcare Conference, where they will present a company overview and meet with investors.</p>
<div class="lb-trans"><p>Neurogene Inc. (NGNE) 上漲 2.06%，收於 18.29 美元，上漲 0.37 美元。本週早些時候，Neurogene 宣佈其管理團隊將參加第 44 屆年度摩根大通醫療保健會議，屆時他們將介紹公司概況並與投資者會面。</p>
</div><p>China SXT Pharmaceuticals, Inc. (SXTC) also advanced 2.06% to $18.29, up $0.37. The company recently disclosed a definitive agreement with a single investor for the purchase of 66,666,666 Class A ordinary shares (or pre-funded warrants) at $0.15 per share in a registered direct offering. The financing move highlights ongoing efforts to strengthen its capital position.</p>
<div class="lb-trans"><p>China SXT Pharmaceuticals, Inc. (SXTC) 也上漲 2.06%，至 18.29 美元，上漲 0.37 美元。該公司最近披露與單一投資者達成了一項最終協議，購買 66666666 股 A 類普通股（或預先融資的認股權證），每股價格為 0.15 美元，屬於註冊直接發行。這一融資舉措突顯了其加強資本狀況的持續努力。</p>
</div><p>For comments and feedback contact: editorial@rttnews.com</p>
<div class="lb-trans"><p>如需評論和反饋，請聯繫：editorial@rttnews.com</p>
</div><p>Business News</p>
<div class="lb-trans"><p>商業新聞</p>
</div>

盤後股價上漲：ZeZentalis Pharma、LifeMD 和 Nanoviricides 是漲幅最大的股票之一